Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name ↓	B/G	Ingredients	Dosage	Form	Price
S01AA26	AZYTER	G	Azithromycin (dihydrate) - 15mg/g	15mg/g	Drops solution	412,560 L.L
J01FA10	AZOX 250	G	Azithromycin (dihydrate) - 250mg	250mg	Tablet, film coated	354,774 L.L
J01FA10	AZOX 250	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	346,711 L.L
S01EC04	AZOPT	B	Brinzolamide - 10mg/ml	10mg/ml	Drops suspension	804,962 L.L
D07XC04	AZONIT - D	G	Diflucortolone valerate - 1mg/g, Isoconazole nitrate - 10mg/g		Cream	225,766 L.L
J01FA10	AZOMYNE	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	385,683 L.L
J01FA10	AZOMYNE	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension	237,860 L.L
J01FA10	AZOMYCIN	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	361,494 L.L
J01FA10	AZOMYCIN	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension	693,423 L.L
J01FA10	AZOMYCIN	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension + solvent	365,525 L.L
J01FA10	AZM-500	G	Azithromycin - 500mg	500mg	Tablet, film coated	448,843 L.L
J01FA10	AZIFAST 500	G	Azithromycin - 500mg	500mg	Tablet, film coated	573,373 L.L
J01FA10	AZIFAST 250	G	Azithromycin - 250mg	250mg	Tablet, film coated	423,630 L.L
J01FA10	AZICIN 500 BENTA	G	Azithromycin - 500mg	500mg	Tablet, film coated	573,373 L.L
J01FA10	AZICIN 250 BENTA	G	Azithromycin - 250mg	250mg	Tablet, film coated	423,630 L.L
L01BC07	AZACITIDINE SPC	G	Azacitidine - 100mg	100mg	Injectable powder	10,706,993 L.L
L01BC07	AZACITIDINE SHILPA	G	Azacitidine - 100mg	100mg	Injectable powder	7,350,062 L.L
L01BC07	AZACITIDINE NEAPOLIS	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	9,401,575 L.L
L01BC07	AZACITIDINE EVER PHARMA	G	Azacitidine - 100mg/100ml	25mg/ml	Injectable powder for suspension	10,967,854 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
J01CR02	AYECLAV-T	G	Amoxicillin - 875mg, Clavulanic Acid - 125mg		Tablet	338,648 L.L
J01DD04	AXONE 500MG IM	G	Ceftriaxone (sodium) - 500mg	500mg	Injectable powder for solution+diluent	393,746 L.L
J01DD04	AXONE 1G IM	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	438,093 L.L
J01DD04	AXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	4,047,654 L.L
A02BC01	AXIPRON	G	Omeprazole - 20mg	20mg	Capsule	373,358 L.L
J01DC02	AXETINE	G	Cefuroxime sodium - 1.5g	1.5g	Injectable powder for solution	2,273,782 L.L
J01DC02	AXETINE	G	Cefuroxime sodium - 750mg	750mg	Injectable powder for solution	1,193,332 L.L
D10AD01	AVOTIN-A	G	Tretinoin - 0.05%	0.05%	Cream	440,780 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
L03AB07	AVONEX	BioTech	Interferon beta-1a - 30mcg/0.5ml	30mcg/0.5ml	Injectable solution	70,488,764 L.L

...